Bayer HealthCare Marks 2010 World Hemophilia Day with EUR 250,000 Contribution
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Novo Nordisk launches international survey into the psychosocial effects of living with haemophilia
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
Long-term efficacy and tolerability of Vimpat® (lacosamide)
- Details
- Category: Clinical Trials
UCB's antiepileptic drug (AED) Vimpat® (lacosamide) featured in several studies and analyses presented at the 62nd annual American Academy of Neurology (AAN) meeting. These data offer additional clinical evidence supporting the use of lacosamide as adjunctive therapy in the treatment of adult patients with partial-onset seizures.
Stemgent and Pfizer Announce Collaboration
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Roche acquires Medingo Ltd. and expands its position in the growing insulin delivery systems market
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Additional Alemtuzumab Mechanism of Action Data Reported
- Details
- Category: Genzyme
![Genzyme Corporation Genzyme Corporation](http://www.worldpharmanews.com/images/stories/logo/genzyme.gif)
A potential first-in-class, once-daily oral therapy for relapsing forms of multiple sclerosis
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
More Pharma News ...
- Sanofi-aventis and CureDM Sign Exclusive Worldwide License Agreement
- Nycomed and Baxter receive FDA approval for TachoSil®
- Novel agent Lu AE04621 enters Lundbeck's development pipeline
- Boehringer Ingelheim launches Global Venture Fund to foster innovation in life sciences
- GSK and Isis Pharmaceuticals collaborate on RNA therapeutics
- Pfizer Posts Details About Interactions With U.S. Physicians
- Novo Nordisk Introduces New Industry Resource for Information on Diabetes and Chronic Disease